Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Open access
Pearse, Roger N., Sordillo, Emilia M., Yaccoby, Shmuel, Wong, Brian R., Liau, Deng F., Colman, Neville, Michaeli, Joseph, Epstein, Joshua, Choi, Yongwon · 2001 · Proceedings of the National Academy of Sciences

Abstract

Bone destruction, caused by aberrant production and activation of osteoclasts, is a prominent feature of multiple myeloma. We demonstrate that myeloma stimulates osteoclastogenesis by triggering a coordinated increase in the tumor necrosis factor-related activation-induced cytokine (TRANCE) and decrease in its decoy receptor, osteoprotegerin (OPG). Immunohistochemistry and in situ hybridization studies of bone marrow specimens indicate that in vivo , deregulation of the TRANCE–OPG cytokine axis occurs in myeloma, but not in the limited plasma cell disorder monoclonal gammopathy of unknown significance or in nonmyeloma hematologic malignancies. In coculture, myeloma cell lines stimulate expression of TRANCE and inhibit expression of OPG by stromal cells. Osteoclastogenesis, the functional consequence of increased TRANCE expression, is counteracted by addition of a recombinant TRANCE inhibitor, RANK-Fc, to marrow/myeloma cocultures. Myeloma–stroma interaction also has been postulated to support progression of the malignant clone. In the SCID-hu murine model of human myeloma, administration of RANK-Fc both prevents myeloma-induced bone destruction and interferes with myeloma progression. Our data identify TRANCE and OPG as key cytokines whose deregulation promotes bone destruction and supports myeloma growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.201394498

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 6

  1. I Van Riet Pathol Biol 47, 98–108 (1999).
  2. 10.1002/(SICI)1097-0142(19971015)80:8 <1557::AID-CNCR5>3.0.CO;2-H · doi:10.1002/(sici)1097-0142(19971015)80:8
  3. Y W Huang, J A Richardson, A W Tong, B Q Zhang, M J Stone, E S Vitetta Cancer Res 53, 1392–1396 (1993).
  4. 10.1210/endo.140.4.6647 · doi:10.1210/endo.140.4.6647 · Paper page
  5. K H Burk, B Drewinko, J M Turjillo, M J Ahearn Cancer Res 38, 2508–2513 (1978).
  6. C Capparelli, P J Kostenuik, S Morony, C Starnes, B Weimann, G Van, S Scully, M Qi, D L Lacey, C R Dunstan Cancer Res 60, 783–787 (2000).

Cited by

See all 518

Metadata

Authors
Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y.
Affiliations
St. Luke's-Roosevelt Hospital Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2001-09-18
Volume
98
Issue
20
Pages
11581-11586
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2066000727
Cited by
518
References
49
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 13 · 2021: 19 · 2020: 7 · 2019: 7 · 2018: 11 · 2017: 21 · 2016: 13 · 2015: 12 · 2014: 23 · 2013: 23 · 2012: 24
FWCI
15.30
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
multiple myeloma, trance, osteoprotegerin, RANK, osteoclastogenesis, bone destruction, tumor progression, monoclonal gammopathy of undetermined significance, mesenchymal stem cells
MeSH terms
Tartrate-Resistant Acid Phosphatase, Acid Phosphatase, Animals, Carrier Proteins, Glycoproteins, Hodgkin Disease, Humans, Isoenzymes, Membrane Glycoproteins, Paraproteinemias, Reference Values, Time Factors, Leukemia, Lymphocytic, Chronic, B-Cell, Mice, SCID, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Disease Progression, Reverse Transcriptase Polymerase Chain Reaction, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. https://app.cochat.ai/papers/10.1073/pnas.201394498
The paper
Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y. (2001). Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.201394498

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.